Many people in the United States take medications called proton pump inhibitors, or PPIs, to help with heartburn, acid reflux ...

Americans who took proton pump inhibitors, or PPIs, for four-and-a-half years or longer were 33% more likely to develop ...

The study found people who used proton pump inhibitors for more than 4.4 years were 33% more likely to be diagnosed with the ...

Neurologists have discovered that a common household drug, which has been previously linked to higher risk of stroke, broken ...

Regularly taking this tablet could increase the risk of developing the degenerative disease by as much as a third.

Doctors have warned about the risks of long-term use of the drug, which has also been linked to strokes, bone fractures and ...

After adjusting for factors such as age, sex and race, as well as health-related issues such as high blood pressure and ...

Results from the dual Phase III TRIUMpH trials demonstrated the statistical superiority of tegoprazan over lansoprazole in ...

Braintree Laboratories, a part of Sebela Pharmaceuticals® and a leading manufacturer of gastroenterology pharmaceutical products, today announced positive topline results from two pivotal US Phase 3 ...

Background: Proton pump inhibitors (PPIs) have been linked to increased risk of heart and kidney disease, but causal mechanisms remain to be elucidated. Cross-sectional studies have linked PPI use ...

An urgent recall has been issued due to a safety concern that has been identified in a popular heat pump system sold in Ireland. Ireland's Competition and Consumer Protection Commission (CCPC ...